Prescription Drugs Market Research Reports & Industry Analysis
The prescription drugs industry is a key cornerstone of healthcare, delivering vital medications that improve and save lives. As this industry continues to evolve, understanding its nuances can be an ongoing challenge. MarketResearch.com provides hundreds of authoritative prescription drugs market research reports to help stakeholders understand the shifting market landscape and devise effective business strategies.
The Latest Prescription Drugs Market Analysis
- We provide data-packed reports on a wide range of product types, therapeutic areas, regions, and companies.
- Our research includes in-depth analyses of prescription drug market size, growth forecasts, and drivers and challenges.
- In addition, we cover the rise of personalized medicine and gene therapies, as well as regulatory issues and pricing models.
Your Dedicated Research Partner
As the prescription drugs industry shifts and changes, MarketResearch.com equips you with the tools to thrive. Trusted for decades as a reliable research partner, our clients include top pharmaceutical companies, investment banks, and universities. Whether you are exploring new markets or seeking to futureproof your business, our prescription drugs industry research reports offer a wealth of knowledge to inform your strategy. Get started by exploring our vast selection of reports on the prescription drugs industry today.
Prescription Drugs Industry Research & Market Reports
-
Jalyn - API Insight, 2022
... and other development activities. It further provides Jalyn's patents information (US & EU). It also features the historical and forecasted sales of Jalyn 2024. The report also highlights Jalyn's market competition and emerging therapies which ... Read More
-
Loestrin 24 Fe - API Insight, 2022
... milestones, deals & partnerships, clinical trials and other development activities. It further provides Loestrin 24 Fe's patents information (US & EU). It also features the historical and forecasted sales of Loestrin 24 Fe 2024. The ... Read More
-
Metgluco - API Insight, 2022
... and other development activities. It further provides Metgluco's patents information (US & EU). It also features the historical and forecasted sales of Metgluco 2024. The report also highlights Metgluco's market competition and emerging therapies which ... Read More
-
Sutent - API Insight, 2022
... and other development activities. It further provides Sutent's patents information (US & EU). It also features the historical and forecasted sales of Sutent 2024. The report also highlights Sutent's market competition and emerging therapies which ... Read More
-
Vidaza - API Insight, 2022
... and other development activities. It further provides Vidaza's patents information (US & EU). It also features the historical and forecasted sales of Vidaza 2024. The report also highlights Vidaza's market competition and emerging therapies which ... Read More
-
Xyzall - API Insight, 2022
... and other development activities. It further provides Xyzall's patents information (US & EU). It also features the historical and forecasted sales of Xyzall 2024. The report also highlights Xyzall's market competition and emerging therapies which ... Read More
-
Women’s Health Diagnostics Market Segmentation by Application (Breast Cancer, Infectious Disease Testing, Osteoporosis Testing, Pregnancy & Fertility Testing, Sexually Transmitted Disease Testing, and Others); and by End User (Hospitals, Clinics, and Home Care) – Global Demand Analysis & Opportunity Outlook 2030
... Demand Analysis & Opportunity Outlook 2030 Market Overview Fatpos Global has released a report titled Women’s Health Diagnostics Market - Analysis of Market Size, Share & Trends for 2014 - 2020 and Forecasts to 2031. ... Read More
-
Oral Antidiabetic Drugs Market By Drugs Class (Sulfonylureas (Glimepiride, Gliclazide, Glyburide, Others), Meglitinides, Repaglinide, Nateglinide, Biguanides (Metformin, Others), Alpha-Glucosidase Inhibitors (Acarbose, Voglibose, Others), Others, By Type (Type 1 Diabetes, Type 2 Diabetes), By End User (Hospital, Pharmacy Store, Drug Store, Diabetics Treatment Centres, Others) - Global Industry Perspective, Comprehensive Analysis And Forecast, 2020 – 2030
... (Hospital, Pharmacy Store, Drug Store, Diabetics Treatment Centres, Others) - Global Industry Perspective, Comprehensive Analysis And Forecast, 2020 – 2030 Market Overview Fatpos Global has released a report titled Oral Antidiabetic Drugs Market - Analysis ... Read More
-
11 Beta-Hydroxysteroid Dehydrogenase (11ßHSD) Inhibitor - Pipeline Insight, 2022
... report provides detailed coverage of the pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete pipeline analysis by developmental stage, associated indications, route of administration and molecule type. Pipeline ... Read More
-
1,3-Beta-Glucan Synthase Inhibitor - Pipeline Insight, 2022
... of the pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete pipeline analysis by developmental stage, associated indications, route of administration and molecule type. Pipeline Products covered across the ... Read More
-
5-HT1B Antagonist - Pipeline Insight, 2022
... pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete pipeline analysis by developmental stage, associated indications, route of administration and molecule type. Pipeline Products covered across the following Developmental ... Read More
-
5-HT1D Agonist - Pipeline Insight, 2022
... pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete pipeline analysis by developmental stage, associated indications, route of administration and molecule type. Pipeline Products covered across the following Developmental ... Read More
-
Isentress - API Insight, 2022
... and other development activities. It further provides Isentress's patents information (US & EU). It also features the historical and forecasted sales of Isentress 2024. The report also highlights Isentress's market competition and emerging therapies which ... Read More
-
Nexplanon - API Insight, 2022
... and other development activities. It further provides Nexplanon's patents information (US & EU). It also features the historical and forecasted sales of Nexplanon 2024. The report also highlights Nexplanon's market competition and emerging therapies which ... Read More
-
Plavix - API Insight, 2022
... and other development activities. It further provides Plavix's patents information (US & EU). It also features the historical and forecasted sales of Plavix 2024. The report also highlights Plavix's market competition and emerging therapies which ... Read More
-
Reyataz - API Insight, 2022
... and other development activities. It further provides Reyataz's patents information (US & EU). It also features the historical and forecasted sales of Reyataz 2024. The report also highlights Reyataz's market competition and emerging therapies which ... Read More
-
Trioptal - API Insight, 2022
... and other development activities. It further provides Trioptal's patents information (US & EU). It also features the historical and forecasted sales of Trioptal 2024. The report also highlights Trioptal's market competition and emerging therapies which ... Read More
-
Xarelto - API Insight, 2022
... and other development activities. It further provides Xarelto's patents information (US & EU). It also features the historical and forecasted sales of Xarelto 2024. The report also highlights Xarelto's market competition and emerging therapies which ... Read More
-
Opioid-Induced Constipation - Epidemiology Forecast to 2032
... France, and the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan Study Period: 2019-2032 Opioid-Induced Constipation Understanding The DelveInsight Opioid-Induced Constipation ... Read More
-
Alpha-2 Agonist - Pipeline Insight, 2022
... pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete pipeline analysis by developmental stage, associated indications, route of administration and molecule type. Pipeline Products covered across the following Developmental ... Read More
-
Alpha-2 Antagonist - Pipeline Insight, 2022
... pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete pipeline analysis by developmental stage, associated indications, route of administration and molecule type. Pipeline Products covered across the following Developmental ... Read More
-
Retinoic Acid Receptors (RARs) Agonist - Pipeline Insight, 2022
... report provides detailed coverage of the pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete pipeline analysis by developmental stage, associated indications, route of administration and molecule type. Pipeline ... Read More
-
Abilify - API Insight, 2022
... and other development activities. It further provides Abilify's patents information (US & EU). It also features the historical and forecasted sales of Abilify 2024. The report also highlights Abilify's market competition and emerging therapies which ... Read More
-
Anoro Ellipta - API Insight, 2022
... partnerships, clinical trials and other development activities. It further provides Anoro Ellipta's patents information (US & EU). It also features the historical and forecasted sales of Anoro Ellipta 2024. The report also highlights Anoro Ellipta's ... Read More
-
Byetta - API Insight, 2022
... and other development activities. It further provides Byetta's patents information (US & EU). It also features the historical and forecasted sales of Byetta 2024. The report also highlights Byetta's market competition and emerging therapies which ... Read More
Research Assistance
